Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""CLINICAL trials"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-25 z 351721

Starter badań:

Tytuł:
Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.
Autorzy:
Barber VS; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK. .
Calvert C; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK.
Appelbe D; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK.
Sprange K; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, UK.
Nollett C; Centre for Trials Research, Cardiff University, Cardiff, UK.
Tanner S; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK.
Richards DB; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 28; Vol. 25 (1), pp. 224. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Humans ; Research Design ; Surveys and Questionnaires ; United Kingdom
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.
Autorzy:
Smith KL; Sidney Kimmel Comprehensive Cancer Center, Women's Malignancies Disease Group, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mead-Harvey C; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Mazza GL; Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Arizona, USA.
Shinn EH; Department of Behavioral Science, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Frank ES; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Melisko ME; Department of Medicine (Hematology/Oncology), University of California, San Francisco, California, USA.
Eaton C; Biostatistics, Epidemiology and Data Management Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Liu Y; Biostatistics, Epidemiology and Data Management Core, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Salamone JM; Georgetown Breast Cancer Advocates, Washington, District of Columbia, USA.
Pollastro T; University of Washington, Seattle, Washington, USA.
Spears PA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Caston NE; Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Women's Malignancies Disease Group, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Rocque GB; Division of Hematology and Oncology, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.; Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7090.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/therapy
Pandemics*
Clinical Trials as Topic*
Patient Participation*
Female ; Humans ; Anxiety/etiology ; Surveys and Questionnaires
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio.
Autorzy:
Leggett H; York Trials Unit, The University of York, York, United Kingdom.
Vinall-Collier K; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Csikar J; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Barber S; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Carr R; York Trials Unit, The University of York, York, United Kingdom.
Bhatti A; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Pavitt S; School of Dentistry, The University of Leeds, Leeds, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 21; Vol. 19 (2), pp. e0296343. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
COVID-19*/epidemiology
Aged ; Humans ; Communication ; Focus Groups ; Pandemics ; Trust
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Group sequential designs for pragmatic clinical trials with early outcomes: methods and guidance for planning and implementation.
Autorzy:
Parsons NR; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK. .
Basu J; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK.
Stallard N; Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, CV4 7AL, Coventry, UK.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2024 Feb 16; Vol. 24 (1), pp. 42. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:
Journal Article
MeSH Terms:
Research Design*
Pragmatic Clinical Trials as Topic*
Humans ; Computer Simulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review of brachytherapy clinical trials: a cross-sectional analysis of ClinicalTrials.gov.
Autorzy:
Chen D; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Parsa R; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Chauhan K; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.
Lukovic J; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Han K; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada.; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Taggar A; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Raman S; Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, ON, Canada. .; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. .; Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2024 Feb 13; Vol. 19 (1), pp. 22. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brachytherapy*
Clinical Trials as Topic*
Female ; Humans ; Male ; Cross-Sectional Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Good Statistical Practice-development of tailored Good Clinical Practice training for statisticians.
Autorzy:
Stocken DD; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK. .
Mossop H; Biostatistics Research Group, Institute of Health and Society, Newcastle University, Newcastle Upon Tyne, UK.
Armstrong E; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Lewis S; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Dutton SJ; Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Peckitt C; Royal Marsden and Institute for Cancer Research Clinical Trials Units, The Royal Marsden NHS Foundation Trust, London, UK.
Gamble C; Liverpool Clinical Trials Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, UK.
Brown J; Leeds Institute of Clinical Trials Research, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Feb 10; Vol. 25 (1), pp. 113. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Statistics as Topic*/standards
Clinical Trials as Topic*
Humans ; Reproducibility of Results
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Strategies for enhancing the representation of women in clinical trials: an evidence map.
Autorzy:
Goldstein KM; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA. .; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA. .
Kung LCY; Health Management & Policy, Graduate School of Public Health, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182-4162, USA.
Dailey SA; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.
Kroll-Desrosiers A; VA Central Western Massachusetts Healthcare System, 421 North Main Street, Leeds, MA, 01053, USA.; UMass Chan Medical School, 55 Lake Ave. N, Worcester, MA, 01655, USA.
Burke C; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Shepherd-Banigan M; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.; Duke-Margolis Center for Health Policy, 100 Fuqua Drive, Box 90120, Durham, NC, 27708, USA.
Lumsden R; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA.
Sims C; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Duke Rheumatology Division, 40 Duke Medicine Circle Clinic 1j, Durham, NC, 27710, USA.
Schexnayder J; University of Alabama at Birmingham School of Nursing, NB545 1720 2nd, Ave S, Birmingham, AL, 35294, USA.
Patel D; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.
Cantrell S; Duke University Medical Center Library & Archives, Duke University School of Medicine 10 Searle Drive, Durham, NC, 27710, USA.
Sheahan KL; JSI, 2733 Crystal Drive, Arlington, VA, 22202, USA.
Gierisch JM; Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, 508 Fulton Street, Durham, NC, 27705, USA.; Division of General Internal Medicine, Duke University School of Medicine, 40 Duke Medicine Circle, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, 215 Morris Street, Durham, NC, 27701, USA.
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2024 Jan 02; Vol. 13 (1), pp. 2. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Women*
Patient Selection*
Female ; Humans ; Male ; Gender Identity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data.
Autorzy:
Moraga Alapont P; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Prieto P; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Urroz M; Pharmacology and Therapeutics Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Jiménez M; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Carcas AJ; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Pharmacology and Therapeutics Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Borobia AM; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Pharmacology and Therapeutics Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2654-2664. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Patient Selection*
Adult ; Child ; Humans ; Research Design
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acceptance Factors and Psychological Investigation of Clinical Trials in Cancer Patients.
Autorzy:
Sun J; School of Management, Hefei University of Technology, 230039, China.; School of Health Care Management, Anhui Medical University, Hefei, Anhui 230032, China.; Clinical Medical College, Anhui Medical University, Hefei, Anhui 230031, China.
Fang J; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Zhang C; First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.
Jia N; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Zhao W; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Gao J; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Huang Y; First Clinical Medical College, Anhui Medical University, Hefei, Anhui 230032, China.
Hao J; First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.
Zhang L; School of Marxism, Anhui Medical University, Hefei, Anhui 230032, China.
Pokaż więcej
Źródło:
Behavioural neurology [Behav Neurol] 2023 Nov 24; Vol. 2023, pp. 5617575. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/drug therapy
Neoplasms*/psychology
Clinical Trials as Topic*
Patient Participation*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Design, implementation, and inferential issues associated with clinical trials that rely on data in electronic medical records: a narrative review.
Autorzy:
Leviton A; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. .
Loddenkemper T; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Nov 16; Vol. 23 (1), pp. 271. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Electronic Health Records*
Clinical Trials as Topic*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimal trial design selection: a comparative analysis between two-arm and three-arm trials incorporating network meta-analysis for evaluating a new treatment.
Autorzy:
Ye F; Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA, USA.
Wang C; Department of Statistics, College of Liberal Arts and Sciences, Iowa State University, Ames, IA, USA. .; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA. .
O'Connor AM; Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.; Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Nov 11; Vol. 23 (1), pp. 267. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:
Meta-Analysis; Journal Article
MeSH Terms:
Clinical Trials as Topic*
Research Design*
Humans ; Computer Simulation ; Network Meta-Analysis ; Sample Size
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023.
Autorzy:
Parker RA; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Sep 11; Vol. 24 (1), pp. 579. Date of Electronic Publication: 2023 Sep 11.
Typ publikacji:
Letter
MeSH Terms:
Research Personnel*
Clinical Trials as Topic*
Humans ; Research Design
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?
Autorzy:
Steele L; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Lee HL; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Maruthappu T; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
O'Toole EA; Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.; Department of Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1290-1292. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Trials as Topic*
Publication Bias*
Registries*
Alopecia Areata/*drug therapy
Janus Kinase Inhibitors/*therapeutic use
Databases, Factual ; Early Termination of Clinical Trials ; Humans ; Meta-Analysis as Topic ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis.
Autorzy:
Parker JL; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Kuzulugil SS; St Michael's Hospital, Toronto, ON, Canada.
Pereverzev K; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Mac S; Institute of Health Policy, Management and Evaluation, University of Toronto, Mississauga, ON, Canada.
Lopes G; University of Miami, Miller School of Medicine, Coral Gables, FL, USA.
Shah Z; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Weerasinghe A; Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.
Rubinger D; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Falconi A; Department of Pharmacy, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Bener A; Mechanical and Industrial Engineering, Ryerson University, Toronto, ON, Canada.
Caglayan B; Mechanical and Industrial Engineering, Ryerson University, Toronto, ON, Canada.
Tangri R; Department of Biology, University of Toronto Mississauga, Mississauga, ON, Canada.
Mitsakakis N; Institute of Health Policy, Management and Evaluation, and Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 1955-1963. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*/classification
Biomarkers, Tumor*/genetics
Clinical Trials as Topic*/classification
Clinical Trials as Topic*/statistics & numerical data
Drug Approval*/methods
Drug Approval*/statistics & numerical data
Markov Chains*
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Breast Neoplasms/chemistry ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Carcinoma, Non-Small-Cell Lung/chemistry ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/genetics ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/chemistry ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Databases, Factual/statistics & numerical data ; Female ; Genetic Markers ; Humans ; Lung Neoplasms/chemistry ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Male ; Medical Oncology ; Melanoma/chemistry ; Melanoma/drug therapy ; Melanoma/genetics ; Neoplasms/chemistry ; Neoplasms/genetics ; Risk ; Skin Neoplasms/chemistry ; Skin Neoplasms/drug therapy ; Skin Neoplasms/genetics ; Stochastic Processes ; Time Factors ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies.
Autorzy:
Modi ND; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Kichenadasse G; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.; Flinders Centre for Innovation in Cancer, Department of Medical Oncology, Flinders Medical Centre, Adelaide, SA, Australia.
Hoffmann TC; Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.
Haseloff M; Adelaide, Australia.
Logan JM; Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Veroniki AA; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.; Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Venchiarutti RL; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.; Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, NSW, Australia.
Smit AK; The Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW, Australia.
Tuffaha H; Centre for the Business and Economics of Health, The University of Queensland, Brisbane, QLD, Australia.
Jayasekara H; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia.
Manning-Bennet A; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Morton E; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
McKinnon RA; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Rowland A; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Sorich MJ; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Oct 23; Vol. 21 (1), pp. 400. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Information Dissemination*
Clinical Trials as Topic*
Humans ; Policy ; Drug Industry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study.
Autorzy:
Mendiratta J; Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase 1, Bengaluru, Karnataka, India.
Vaswani RN; Yenepoya Deemed to be University, University Road Deralakatte, Mangaluru, Karnataka, India.
Saberwal G; Institute of Bioinformatics and Applied Biotechnology, Biotech Park, Electronics City Phase 1, Bengaluru, Karnataka, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 20; Vol. 18 (9), pp. e0284434. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Clinical Trials as Topic*
Humans ; Cross-Sectional Studies ; Databases, Factual ; India ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Motivations for paediatric vaccine trial participation.
Autorzy:
Hillson K; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. .; Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK. .; Oxford, UK. .
Kantor J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Department of Engineering Science, University of Oxford, Oxford, UK.; Florida Center for Dermatology, St Augustine, USA.
Pinto MV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.; Hospital Dona Estefânia, CHULC, Lisbon, Portugal.
Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Kelly D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Vanderslott S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.; Centre for Clinical Vaccinology and Tropical Medicine, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Pokaż więcej
Corporate Authors:
AWARE clinical trial team
Źródło:
Trials [Trials] 2023 Sep 08; Vol. 24 (1), pp. 574. Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Letter
MeSH Terms:
Vaccines*
Clinical Trials as Topic*
Child ; Humans ; Motivation
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective.
Autorzy:
Enomoto T; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan. .
Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
Kim JH; Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Lai CH; Gynecologic Cancer Research Center, Cheng Gung Memorial Hospital, Taoyuan, Taiwan.
Wu X; Department of Gynecologic Oncology, Fudan University Cancer Institute, Shanghai, P.R. China.
Kim YM; Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2023 Sep; Vol. 34 (5), pp. e86. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Genital Neoplasms, Female*/therapy
Uterine Cervical Neoplasms*/therapy
Clinical Trials as Topic*
Female ; Humans ; Asia ; Japan
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The urgent need for conducting clinical trials in pediatric nephrology globally.
Autorzy:
Wightman A; Department of Pediatrics, Divisions of Nephrology, Bioethics and Palliative Care, University of Washington School of Medicine, Seattle, WA, USA.
Filler G; Department of Pediatrics, Schulich School of Medicine & Dentistry, Western University, London, ON, N6A 5W9, Canada.; Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, N5A 5A5, Canada.; Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, ON, N6A 5W9, Canada.; The Lilibeth Caberto Kidney Clinical Research Unit, London Health Sciences Centre, London, ON, Canada.
Díaz-González de Ferris ME; Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. maria_.
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2023 Aug; Vol. 38 (8), pp. 2499-2506. Date of Electronic Publication: 2023 Feb 04.
Typ publikacji:
Editorial
MeSH Terms:
Nephrology*
Clinical Trials as Topic*
Child ; Humans ; Pediatrics
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Discontinuation and nonpublication of clinical trials in orthopaedic oncology.
Autorzy:
Singh G; Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, CA, 94143, USA.
Wague A; Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, CA, 94143, USA.
Arora A; Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, CA, 94143, USA.
Rao V; Indiana University School of Medicine, Indianapolis, IN, USA.
Ward D; Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, CA, 94143, USA.
Barry J; Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, CA, 94143, USA. .
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Feb 05; Vol. 19 (1), pp. 121. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Orthopedics*
Publishing*
Medical Oncology*
Humans ; Cross-Sectional Studies ; Pharmaceutical Preparations ; Randomized Controlled Trials as Topic ; Clinical Trials, Phase III as Topic ; Clinical Trials, Phase IV as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
Autorzy:
Patel MA; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
Shah JL; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Brinley FJ 4th; Bio-techne: ProteinSimple Inc, San Jose, California, USA.
Abrahamse PH; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
Veenstra CM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA.
Schott AF; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12802-12812. Date of Electronic Publication: 2023 May 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasms*/epidemiology
Neoplasms*/therapy
Patient Selection*
Clinical Trials as Topic*
Aged ; Female ; Humans ; Male ; Logistic Models ; Black or African American
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.
Autorzy:
Ghanipour L; Uppsala University, Uppsala, Sweden.; Department of Surgical Sciences, Gastro Intestinal Surgery, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
Jansson Palmer G; Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Nilsson PJ; Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Nordenvall C; Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, Sweden.
Frödin JE; Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden.
Bexe Lindskog E; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden.
Asplund D; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden.
Swartling T; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Gothenburg, Sweden.
Graf W; Uppsala University, Uppsala, Sweden.; Department of Surgical Sciences, Gastro Intestinal Surgery, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
Birgisson H; Uppsala University, Uppsala, Sweden.; Department of Surgical Sciences, Gastro Intestinal Surgery, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
Syk I; Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Verwaal V; Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Brändstedt J; Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Cashin PH; Uppsala University, Uppsala, Sweden.; Department of Surgical Sciences, Gastro Intestinal Surgery, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 04; Vol. 19 (3), pp. e0294018. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Peritoneal Neoplasms*/drug therapy
Humans ; Clinical Trials, Phase I as Topic ; Fluorouracil/therapeutic use ; Hyperthermic Intraperitoneal Chemotherapy ; Irinotecan ; Multicenter Studies as Topic ; Oxaliplatin/therapeutic use ; Quality of Life ; Randomized Controlled Trials as Topic ; Registries ; Retrospective Studies ; Clinical Trials, Phase III as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
Autorzy:
Tassorelli C; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; Headache Science & Neurorehabilitation Centre, IRCCS C. Mondino Foundation and University of Pavia, Pavia, Italy.
Onishchenko K; AbbVie, London, England.
Halker Singh RB; Mayo Clinic, Scottsdale, AZ, USA.
Duan M; AbbVie, North Chicago, IL, USA.
Dupont-Benjamin L; AbbVie, Courbevoie, France.
Hemstock M; Lumanity, Sheffield, England.
Voller C; Lumanity, London, England.
McAllister P; New England Institute for Neurology & Headache, Stamford, CT, USA.
Nahas SJ; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Gandhi P; AbbVie, Florham Park, NJ, USA.
Ailani J; MedStar Georgetown University Hospital, Washington, DC, USA.
Pokaż więcej
Źródło:
Cephalalgia : an international journal of headache [Cephalalgia] 2024 Feb; Vol. 44 (2), pp. 3331024241235156.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Migraine Disorders*/prevention & control
Migraine Disorders*/drug therapy
Piperidines*
Pyridines*
Pyrroles*
Quality of Life*
Spiro Compounds*
Humans ; Tablets/therapeutic use ; Treatment Outcome ; Clinical Trials, Phase III as Topic ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
Autorzy:
Kryza D; Hospices Civils de Lyon, Lyon, France. .; UNIV Lyon-Université Claude Bernard Lyon 1, LAGEPP UMR 5007 CNRS Villeurbanne, Villeurbanne, 69100, France. .; Centre de médecine nucléaire Lumen, 15 rue Gabriel Sarrazin, cedex 08, Lyon, 69373, France. .
Vinceneux A; Department of Medical Oncology, Centre Leon Bérard, Lyon, France.
Bidaux AS; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Garin G; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Tatu D; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Cropet C; Department of Biostatistics, Centre Leon Berard, Lyon, France.
Badel JN; Lumen Nuclear Medicine Department, Centre Léon Bérard, Lyon, France.
Perol D; Department of Clinical Research, Centre Leon Berard, Lyon, France.
Giraudet AL; Lumen Nuclear Medicine Department, Centre Léon Bérard, Lyon, France. .; Centre de médecine nucléaire Lumen, 15 rue Gabriel Sarrazin, cedex 08, Lyon, 69373, France. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Feb 01; Vol. 24 (1), pp. 163. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Carcinoma, Renal Cell*/radiotherapy
Carcinoma, Renal Cell*/drug therapy
Lutetium*/adverse effects
Lutetium*/therapeutic use
Radioisotopes*/adverse effects
Radioisotopes*/therapeutic use
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/radiotherapy
Antigens, Surface*/metabolism
Glutamate Carboxypeptidase II*/antagonists & inhibitors
Radiopharmaceuticals*/adverse effects
Radiopharmaceuticals*/therapeutic use
Humans ; Male ; Dipeptides/adverse effects ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/adverse effects ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prospective Studies ; Quality of Life ; Treatment Outcome ; Tumor Microenvironment ; Female ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-25 z 351721

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies